Effect of cerebral arteriovenous malformation location on outcomes of repeat, single-fraction stereotactic radiosurgery: a matched-cohort analysis.

arteriovenous malformation intracranial hemorrhage residual stereotactic radiosurgery vascular disorders

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
22 Dec 2023
Historique:
received: 25 08 2023
accepted: 17 10 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: aheadofprint

Résumé

Patients with deep-seated arteriovenous malformations (AVMs) have a higher rate of unfavorable outcome and lower rate of nidus obliteration after primary stereotactic radiosurgery (SRS). The aim of this study was to evaluate and quantify the effect of AVM location on repeat SRS outcomes. This retrospective, multicenter study involved 505 AVM patients managed with repeat, single-session SRS. The endpoints were nidus obliteration, hemorrhage in the latency period, radiation-induced changes (RICs), and favorable outcome. Patients were split on the basis of AVM location into the deep (brainstem, basal ganglia, thalamus, deep cerebellum, and corpus callosum) and superficial cohorts. The cohorts were matched 1:1 on the basis of the covariate balancing score for volume, eloquence of location, and prescription dose. After matching, 149 patients remained in each cohort. The 5-year cumulative probability rates for favorable outcome (probability difference -18%, 95% CI -30.9 to -5.8%, p = 0.004) and AVM obliteration (probability difference -18%, 95% CI -30.1% to -6.4%, p = 0.007) were significantly lower in the deep AVM cohort. No significant differences were observed in the 5-year cumulative probability rates for hemorrhage (probability difference 3%, 95% CI -2.4% to 8.5%, p = 0.28) or RICs (probability difference 1%, 95% CI -10.6% to 11.7%, p = 0.92). The median time to delayed cyst formation was longer with deep-seated AVMs (deep 62 months vs superficial 12 months, p = 0.047). AVMs located in deep regions had significantly lower favorable outcomes and obliteration rates compared with superficial lesions after repeat SRS. Although the rates of hemorrhage in the latency period and RICs in the two cohorts were comparable, delayed cyst formation occurred later in patients with deep-seated AVMs.

Identifiants

pubmed: 38134430
doi: 10.3171/2023.10.JNS231957
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Auteurs

Georgios Mantziaris (G)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Stylianos Pikis (S)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Chloe Dumot (C)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.
2Department of Neurological Surgery, Hospices Civils de Lyon, France.

Sam Dayawansa (S)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Roman Liscak (R)

3Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic.

Jaromir May (J)

3Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic.

Cheng-Chia Lee (CC)

4Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan.
5School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Huai-Che Yang (HC)

4Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan.
5School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Nuria Martínez Moreno (N)

6Radiosurgery Unit, Hospital Ruber Internacional, Madrid, Spain.

Roberto Martinez Álvarez (R)

6Radiosurgery Unit, Hospital Ruber Internacional, Madrid, Spain.

L Dade Lunsford (LD)

7Department of Neurological Surgery, University of Pittsburgh, Pennsylvania.

Ajay Niranjan (A)

7Department of Neurological Surgery, University of Pittsburgh, Pennsylvania.

Zhishuo Wei (Z)

7Department of Neurological Surgery, University of Pittsburgh, Pennsylvania.

Priyanka Srinivasan (P)

7Department of Neurological Surgery, University of Pittsburgh, Pennsylvania.

Lilly W Tang (LW)

7Department of Neurological Surgery, University of Pittsburgh, Pennsylvania.

Ahmed M Nabeel (AM)

8Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt.
9Neurosurgery Department, Benha University, Qalubya, Egypt.

Wael A Reda (WA)

8Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt.
9Neurosurgery Department, Benha University, Qalubya, Egypt.

Sameh R Tawadros (SR)

8Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt.
10Neurosurgery Department and.

Khaled Abdel Karim (K)

8Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt.
21Clinical Oncology Department, Ain Shams University, Cairo, Egypt.

Amr M N El-Shehaby (AMN)

8Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt.
10Neurosurgery Department and.

Reem M Emad Eldin (RM)

8Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt.
11Radiation Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

Ahmed Hesham Elazzazi (AH)

21Clinical Oncology Department, Ain Shams University, Cairo, Egypt.

Selcuk Peker (S)

12Department of Neurosurgery, Koç University School of Medicine, Istanbul, Turkey.

Yavuz Samanci (Y)

12Department of Neurosurgery, Koç University School of Medicine, Istanbul, Turkey.

Varun Padmanaban (V)

13Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Francis J Jareczek (FJ)

13Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

James McInerney (J)

13Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Kevin M Cockroft (KM)

13Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

David Mathieu (D)

14Department of Neurosurgery, University of Sherbrooke, CHUS Research Center, Sherbrooke, Canada.

Salman Aldakhil (S)

14Department of Neurosurgery, University of Sherbrooke, CHUS Research Center, Sherbrooke, Canada.

Juan Diego Alzate (JD)

15Department of Neurosurgery, NYU Langone, New York, New York.

Douglas Kondziolka (D)

15Department of Neurosurgery, NYU Langone, New York, New York.

Manjul Tripathi (M)

16Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Joshua D Palmer (JD)

17Department of Radiation Oncology, The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.

Rituraj Upadhyay (R)

17Department of Radiation Oncology, The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.

Michelle Lin (M)

18Department of Neurosurgery, University of Southern California, Los Angeles, California; and.

Gabriel Zada (G)

18Department of Neurosurgery, University of Southern California, Los Angeles, California; and.

Cheng Yu (C)

18Department of Neurosurgery, University of Southern California, Los Angeles, California; and.

Christopher P Cifarelli (CP)

Departments of19Neurosurgery and.

Daniel T Cifarelli (DT)

20Radiation Oncology, West Virginia University, Morgantown, West Virginia.

Ahmed Shaaban (A)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Zhiyuan Xu (Z)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Jason P Sheehan (JP)

1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Classifications MeSH